Differential regulation of Lndoleamine-2,3-dioxygenase (IDO) by HIV type 1 clade B and C tat protein

AIDS Research and Human Retroviruses

Volumn 25, Issue 3, 2009, Pages 329-335

  Samikkannu, Thangavel ^a   Saiyed, Zainulabedin M ^a   Rao, K V K ^a   Babu, Dakshayani Kadiyala ^a   Rodriguez, Jose W ^b   Papuashvili, Marina N ^a   Nair, Madhavan P N ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b Universidad Central del Caribe School of Medicine   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; RNA; TRANSACTIVATOR PROTEIN;

AMINO ACID SYNTHESIS; ARTICLE; ASTROCYTE; CELL LYSATE; CONTROLLED STUDY; DEMENTIA; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NERVE CELL CULTURE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SUPERNATANT; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; GENE EXPRESSION PROFILING; HOST PATHOGEN INTERACTION; PHYSIOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY;

ASTROCYTES; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAT; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 65449125909     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0225     Document Type: Article

References (33)

1. UNAIDS/WHO: AIDS epidemic update: December 2007. UNAIDS, 2008. UNAIDS/07.27E. JC1322E. ISBN 9789291736218.
2. Price RW, Brew B, Sidtis J, et al.: The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex. Science 1998;239:586-592.
3. Nath A, Haughey NJ, Jones M, et al.: Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine. Ann Neuron 2000;47:186-194.
4. Liang C and Wainberg MA: The role of Tat in HIV-1 replication: An activator and/or a suppressor? AIDS Rev 2002; 4:41-49.
5. Price TO, Ercal N, Nakake R, et al.: HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res 2005;1045:57-63.
6. Nath A: Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 2002; 186(Suppl. 2):S193-198.
7. Satishchandra P, Nalini A, Gourie-Devi M, et al.: Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-1996). Indian J Med Res 2000; 111:14-23.
8. Mishra M, Vetrivel S, Siddappa, NB, et al.: Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: Significance of di-cysteine C30C31 motif. Ann Neurol 2008;63:366-376.
9. Guillemin GJ, Smythe G, Takikawa O, et al.: Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 2004;49:15-23.
10. Shively CA, Mirkes SJ, Lu NZ, et al.: Soy and social stress affect serotonin neurotransmission in primates. Pharmacogenomics J 2003;3:114-121.
11. Lee HJ, Jeong Y, Lee TH, et al.: Rosmarinic acid inhibits indoleamine 2,3-dioxygenase expression in murine dendritic cells. Biochem Pharmacol 2007;73:1412-1421.
12. Grant RS, Naif H, Thuruthyil SJ, et al.: Induction of indolamine [sic] 2,3-dioxygenase in primary human macrophages by human immunodeficiency virus type 1 is strain dependent. J Virol 2000;74:4110-4115.
13. Rao VR, Sas AR, Eugenin EA, et al.: HIV-1 clade-specific differences in the induction of neuropathogenesis. J Neurosci 2008;28:10010-10016.
14. Hegg CC, Hu S, Peterson PK, et al.: Beta-chemokines and human immunodeficiency virus type-1 proteins evoke intracellular calcium increases in human microglia. Neuroscience 2000;98:191-199.
15. Caldwell RL, Gadipatti R,Lane KB,etal.: HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells. J Leukoc Biol 2006;79:192-201.
16. Tadayuki O, Sonia FC, and Gisela V: HIV-1 Tat increases endothelial solute permeability through tyrosine kinase and mitogen-activated protein kinase-dependent pathways. AIDS 2000;14:475-482.
17. Robertson D, Anderson J, Bradac J, Carr J, Foley B, Fun-khouser R, Gao F, Hahn B, Kalish, M, Kuiken C, Learn G, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Salminen OM, Sharp P, Wolinsky SM, and Korber B: A Reference Guide to HIV-1 Classification. Los Alamos National Laboratory, Los Alamos, NM, 2001.
18. Grant I, Sacktor H, and McArthur J: HIV neurocognitive disorders. In: The Neurology of AIDS (Gendelman HE, Grant I, Everall I, Lipton SA, and Swindells S, eds.), 2nd ed. Oxford University Press, London, UK, 2005, pp. 357-373.
19. Shankar AV, Sastry J, Erande A, et al.: Making the choice: The translation of global HIV and infant feeding policy to local practice among mothers in Pune, India. J Nutr 2005; 135:960-965.
20. Wadia RS, Pujari, SN, Kothari S, et al.: Neurological manifestations of HIV disease. J Assoc Physicians India 2001; 49:343-348.
21. Sardar AM and Reynolds GP: Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia. Neurosci Lett 1995;187:9-12.
22. Smith DG, Guillemin GJ, Pemberton L, et al.: Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. J Neurovirol 2001;7:56-60.
23. Valle M, Price RW, Nilsson A, et al.: CSF quinolinic acid levels are determined by local HIV infection: Cross-sectional analysis and modelling of dynamics following antiretroviral therapy. Brain 2004;127:1047-1060.
24. Campbell GR, Watkins JD, Singh KK, et al.: Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. J Virol 2007;81:5919-5928.
25. Siddappa NB, Venkatramanan M, Venkatesh P, et al.: Transactivation and signaling functions of Tat are not correlated: Biological and immunological characterization of HIV-1 subtype-C Tat protein. Retrovirology 2006;18:3:53-73.
26. Albini A, Ferrini S, Benelli R, et al.: HIV-1 Tat protein mimicry of chemokines. Proc Natl Acad Sci USA 1998;95: 13153-13158.
27. Miwa N, Hayakawa S, Miyazaki S, et al.: IDO expression on decidual and peripheral blood dendritic cells and monocytes/ macrophages after treatment with CTLA-4 or interferon-γ increase in normal pregnancy but decrease in spontaneous abortion. Mol Hum Reprod 2005;11:865-870.
28. Thomas SR, Salahifar H, Mashima R, et al.: Antioxidants inhibit indoleamine-2,3-dioxygenase in IFN-gamma-activated human macrophages: Posttranslational regulation by pyrrolidine dithiocarbamate. J Immunol 2001;166:6332-6340.
29. Shirey KA, Jung JY, Maeder GS, et al.: Upregulation of IFN-gamma receptor expression by proinflammatory cytokines influences IDO activation in epithelial cells. J Interferon Cytokine Res 2006;26:53-62.
30. Saha RN and Pahan K: Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia. J Neurochem 2003;86:1057-1071.
31. Mellor AL and Munn DH: IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol 2004;4:762-774.
32. Fallarino F, Vacca C, Orabona C, et al.: Functional expression of indoleamine 2,3-dioxygenase by murine CD8α+dendritic cells. Int Immunol 2002;14:65-68.
33. Potula R, Poluektova L, Knipe B, et al.: Inhibition of in-doleamine 2,3-dioxgygenase (IDO) enhances elimination of virus-infected macrophages in animal model of HIV-1 encephalitis. Blood 2005;106:2382-2390.